An initial dose of 0.3 mg intramuscular (IM) epinephrine was tied to a greater escalation of care than a dose of 0.5 mg in patients with anaphylaxis, a retrospective single-center study found. The ...
NEW YORK (Reuters Health) - Children with a history of food-induced allergic reactions may need more than one shot of epinephrine to halt a severe reaction, a study has confirmed. Among a group of ...
SAN DIEGO, Oct. 03, 2023 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect patients ...
"Market research has shown that there is an unmet need for more patient-friendly alternatives to traditional epinephrine auto-injectors," said David Dworaczyk, Ph.D., CEO of Bryn Pharma. "This study ...
A Prescription Drug User Fee Act target date of January 31, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for epinephrine ...
The Food and Drug Administration approved the first needle-free alternative to the EpiPen on Friday, a single-use epinephrine nasal spray for the emergency treatment of allergic reactions, including ...
ARS Pharma had high hopes that the FDA on Tuesday would approve its flagship product, a needle-free treatment for adults and children with severe allergic reactions. But instead, the drugmaker was set ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results